Literature DB >> 2221520

Predicting the severity of cocaine-associated rhabdomyolysis.

S L Brody1, K D Wrenn, M M Wilber, C M Slovis.   

Abstract

STUDY
OBJECTIVES: The syndrome of rhabdomyolysis associated with cocaine use has been recently described, but the incidence, severity, risk factors, and complications are unknown. This study sought to describe the spectrum of the syndrome and identify clinical features of patients at risk.
DESIGN: Retrospective case series with analysis of common clinical features.
SETTING: Medical emergency department of an urban teaching hospital serving an indigent population. TYPES OF PARTICIPANTS: ED patients with acute cocaine intoxication and a serum creatine kinase (all MM) of more than 500 U/L (8.3 ukat/L) who were admitted for in-hospital management.
MEASUREMENTS AND MAIN RESULTS: Twenty-nine patients, representing 5% of cocaine-related patient visits, were identified over 20 months. Patients were divided into three groups: mild, characterized by anxiety, tachycardia, diaphoresis, dyspnea, or chest pain; moderate, characterized by delirium, agitation, fever, leukocytosis, or an elevated serum creatinine; and severe, characterized by seizure, coma, hypotension, arrhythmia, or cardiac arrest. There was a significant association between the rating system for level of intoxication and the severity of rhabdomyolysis and its complications (P less than .01). Patients at highest risk for complications of rhabdomyolysis were those in the moderate or severe groups.
CONCLUSION: This classification system may be useful for the management of patients with acute cocaine intoxication, predicting those patients in whom aggressive therapy should be initiated in the ED to minimize the complications of rhabdomyolysis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221520     DOI: 10.1016/s0196-0644(05)81518-5

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  9 in total

1.  Comparison of lactated Ringer's solution and 0.9% saline in the treatment of rhabdomyolysis induced by doxylamine intoxication.

Authors:  Young Soon Cho; Hoon Lim; Seung Ho Kim
Journal:  Emerg Med J       Date:  2007-04       Impact factor: 2.740

2.  A case of cocaine-induced myopathy.

Authors:  Vithyalakshmi Selvaraj; Lakshmi Rani Gollamudi; Ashish Sharma; Jayakrishna Madabushi
Journal:  Prim Care Companion CNS Disord       Date:  2013-05-02

Review 3.  Rhabdomyolysis.

Authors:  W H Bagley; H Yang; K H Shah
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

Review 4.  Radiographic Musculoskeletal Findings Indicating Opioid Misuse: An Overview for Orthopedic Surgeons.

Authors:  Harry G Greditzer; Dustin H Massel; Carlos M Barrera; Christopher P Emerson; Michael G Rizzo; Nisreen Ezuddin; Camila Brasil; Ane Ugarte Nuno; Jean Jose
Journal:  HSS J       Date:  2019-01-08

5.  Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.

Authors:  Michele Mitaritonno; Mariarosaria Lupo; Ivana Greco; Angela Mazza; Gianfranco Cervellin
Journal:  Acta Biomed       Date:  2021-04-30

6.  Acute kidney injury associated with endurance events-is it a cause for concern? A systematic review.

Authors:  L E Hodgson; E Walter; R M Venn; R Galloway; Y Pitsiladis; F Sardat; L G Forni
Journal:  BMJ Open Sport Exerc Med       Date:  2017-06-14

Review 7.  Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach.

Authors:  Angel L Montejo; Nieves Prieto; Rubén de Alarcón; Nerea Casado-Espada; Javier de la Iglesia; Laura Montejo
Journal:  J Clin Med       Date:  2019-10-07       Impact factor: 4.241

8.  Rhabdomyolysis related to acute recreational drug toxicity-A Euro-DEN study.

Authors:  Wojciech Waldman; Piotr M Kabata; Alison M Dines; David M Wood; Christopher Yates; Fridtjof Heyerdahl; Knut Erik Hovda; Isabelle Giraudon; Paul I Dargan; Jacek Sein Anand
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

Review 9.  Kynurenic Acid Acts as a Signaling Molecule Regulating Energy Expenditure and Is Closely Associated With Metabolic Diseases.

Authors:  Delong Zhen; Junjun Liu; Xu Dong Zhang; Zehua Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.